Olga Ab

1.4k total citations
23 papers, 776 citations indexed

About

Olga Ab is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Olga Ab has authored 23 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 11 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Molecular Biology. Recurrent topics in Olga Ab's work include HER2/EGFR in Cancer Research (18 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Cancer therapeutics and mechanisms (5 papers). Olga Ab is often cited by papers focused on HER2/EGFR in Cancer Research (18 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Cancer therapeutics and mechanisms (5 papers). Olga Ab collaborates with scholars based in United States and Germany. Olga Ab's co-authors include Jan Pinkas, Victor S. Goldmacher, Laura M. Bartle, Ravi Chari, Rajeeva Singh, Robert J. Lutz, Xiuxia Sun, Thomas Chittenden, Kathleen R. Whiteman and Yelena Kovtun and has published in prestigious journals such as Blood, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Olga Ab

23 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Ab United States 11 577 398 190 99 90 23 776
Amelia M. Huehls United States 10 488 0.8× 144 0.4× 395 2.1× 55 0.6× 32 0.4× 15 704
Bart E.C.G. de Goeij Netherlands 8 408 0.7× 468 1.2× 322 1.7× 70 0.7× 13 0.1× 10 788
Lowell J. Underwood United States 12 244 0.4× 122 0.3× 420 2.2× 146 1.5× 132 1.5× 16 881
Lisa M. Garrett United States 3 503 0.9× 427 1.1× 354 1.9× 26 0.3× 11 0.1× 3 833
H. A. Burris United States 17 534 0.9× 119 0.3× 271 1.4× 49 0.5× 19 0.2× 57 770
Lindsey Rolfe United States 12 622 1.1× 70 0.2× 374 2.0× 36 0.4× 179 2.0× 30 856
Kathrin Schwager Switzerland 14 482 0.8× 487 1.2× 301 1.6× 13 0.1× 23 0.3× 17 1.0k
M. I. Colnaghi Italy 15 585 1.0× 402 1.0× 487 2.6× 24 0.2× 126 1.4× 26 1.1k
Joshua Z. Drago United States 9 742 1.3× 454 1.1× 356 1.9× 14 0.1× 22 0.2× 28 1.1k
A A Epenetos United Kingdom 10 102 0.2× 256 0.6× 147 0.8× 35 0.4× 71 0.8× 13 533

Countries citing papers authored by Olga Ab

Since Specialization
Citations

This map shows the geographic impact of Olga Ab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Ab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Ab more than expected).

Fields of papers citing papers by Olga Ab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Ab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Ab. The network helps show where Olga Ab may publish in the future.

Co-authorship network of co-authors of Olga Ab

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Ab. A scholar is included among the top collaborators of Olga Ab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Ab. Olga Ab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ponte, Jose F., Leanne Lanieri, Eshita Khera, et al.. (2020). Antibody Co-Administration Can Improve Systemic and Local Distribution of Antibody–Drug Conjugates to Increase In Vivo Efficacy. Molecular Cancer Therapeutics. 20(1). 203–212. 29 indexed citations
3.
Shen, Joel, Jing Cao, Vangipuram S. Rangan, et al.. (2020). CX-2043, an EpCAM-targeting probody drug conjugate, demonstrates anti-tumor activity with a favorable safety profile in preclinical models. European Journal of Cancer. 138. S15–S15. 4 indexed citations
4.
Ab, Olga, Laura M. Bartle, Leanne Lanieri, et al.. (2020). Abstract 2890: IMGN151 - A next generation folate receptor alpha targeting antibody drug conjugate active against tumors with low, medium and high receptor expression. Cancer Research. 80(16_Supplement). 2890–2890. 10 indexed citations
5.
Yoder, Nicholas C., Chen Bai, Wayne C. Widdison, et al.. (2019). A Case Study Comparing Heterogeneous Lysine- and Site-Specific Cysteine-Conjugated Maytansinoid Antibody-Drug Conjugates (ADCs) Illustrates the Benefits of Lysine Conjugation. Molecular Pharmaceutics. 16(9). 3926–3937. 30 indexed citations
6.
Archer, Katie E., James R. Woods, Luke Harris, et al.. (2019). Synthesis of Highly Potent N-10 Amino-Linked DNA-Alkylating Indolinobenzodiazepine Antibody–Drug Conjugates (ADCs). ACS Medicinal Chemistry Letters. 10(8). 1211–1215. 9 indexed citations
7.
Archer, Katie E., Alan Wilhelm, Nicholas C. Yoder, et al.. (2019). Effect of Linker Stereochemistry on the Activity of Indolinobenzodiazepine Containing Antibody–Drug Conjugates (ADCs). ACS Medicinal Chemistry Letters. 10(8). 1193–1197. 11 indexed citations
8.
Archer, Katie E., Erin K. Maloney, Olga Ab, et al.. (2019). Design, synthesis and evaluation of novel, potent DNA alkylating agents and their antibody-drug conjugates (ADCs). Bioorganic & Medicinal Chemistry Letters. 29(17). 2455–2458. 5 indexed citations
9.
Qiu, Qifeng, Jose F. Ponte, Leanne Lanieri, et al.. (2019). Peptide-Cleavable Self-immolative Maytansinoid Antibody–Drug Conjugates Designed To Provide Improved Bystander Killing. ACS Medicinal Chemistry Letters. 10(10). 1393–1399. 18 indexed citations
10.
Li, Wěi, Qifeng Qiu, Kerstin W. Sinkevicius, et al.. (2019). Synthesis and Evaluation of Camptothecin Antibody–Drug Conjugates. ACS Medicinal Chemistry Letters. 10(10). 1386–1392. 30 indexed citations
11.
Kovtun, Yelena, Gregory E. Jones, Sharlene Adams, et al.. (2018). A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells. Blood Advances. 2(8). 848–858. 129 indexed citations
12.
Miller, Michael L., Jose F. Ponte, Leanne Lanieri, et al.. (2017). Abstract 53: Antibody-drug conjugates (ADCs) of peptide-linked Indolino-Benzodiazepine (IGN) DNA-alkylator provides improved anti-tumor activity over that of a crosslinker. Cancer Research. 77(13_Supplement). 53–53. 1 indexed citations
13.
14.
Ab, Olga, Kathleen R. Whiteman, Laura M. Bartle, et al.. (2015). IMGN853, a Folate Receptor-α (FRα)–Targeting Antibody–Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors. Molecular Cancer Therapeutics. 14(7). 1605–1613. 160 indexed citations
15.
Ab, Olga, Laura M. Bartle, Lingyun Rui, et al.. (2011). Abstract 4576: IMGN853, an anti-Folate Receptor I antibody-maytansinoid conjugate for targeted cancer therapy. Cancer Research. 71(8_Supplement). 4576–4576. 7 indexed citations
16.
Kovtun, Yelena, Charlene A. Audette, Michele Mayo, et al.. (2010). Antibody-Maytansinoid Conjugates Designed to Bypass Multidrug Resistance. Cancer Research. 70(6). 2528–2537. 194 indexed citations
17.
Aigner, Silke, Olga Ab, Kathleen R. Whiteman, et al.. (2010). BT062, a CD138-Specific Immunoconjugate, Demonstrates Superior In Vivo Anti-Myeloma Efficacy In Combination with Lenalidomide or Bortezomib. Blood. 116(21). 3008–3008. 5 indexed citations
18.
Whiteman, Kathleen R., Holly A. Johnson, Shanqin Xu, et al.. (2009). Abstract #2799: Combination therapy with IMGN901 and lenalidomide plus low-dose dexamethasone is highly effective in multiple myeloma xenograft models. Cancer Research. 69. 2799–2799. 6 indexed citations
19.
Whiteman, Kathleen R., et al.. (2008). Efficacy of IMGN901 (huN901-DM1) in combination with bortezomib and lenalidomide against multiple myeloma cells in preclinical studies. Cancer Research. 68. 2146–2146. 11 indexed citations
20.
Miller, Michael L., Robert Y. Zhao, Barbara A. Leece, et al.. (2004). Synthesis of Taxoids with Improved Cytotoxicity and Solubility for Use in Tumor-Specific Delivery. Journal of Medicinal Chemistry. 47(20). 4802–4805. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amelia M. Huehls Breakdown of academic impact, for papers by Bart E.C.G. de Goeij Breakdown of academic impact, for papers by Lowell J. Underwood Breakdown of academic impact, for papers by Lisa M. Garrett Breakdown of academic impact, for papers by H. A. Burris Breakdown of academic impact, for papers by Lindsey Rolfe Breakdown of academic impact, for papers by Kathrin Schwager Breakdown of academic impact, for papers by M. I. Colnaghi Breakdown of academic impact, for papers by Joshua Z. Drago Breakdown of academic impact, for papers by A A Epenetos
Rankless by CCL
2026